ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,405Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 117

$450K Total Retail Price of All Prescriptions

Rank: 40 out of 117

283 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 283 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

11% of this provider’s 283 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

0% of this provider’s 9,067 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
DONEPEZIL HCL 692 679 1 10
FUROSEMIDE 526 516 2 3
LEVOTHYROXINE SODIUM 352 344 3 2
WARFARIN SODIUM 317 287 4 9
NAMENDA 302 290 5 14
SIMVASTATIN 289 284 6 1
LISINOPRIL 289 288 6 4
GABAPENTIN 249 237 8 16
SERTRALINE HCL 220 199 9 22
TRAMADOL HCL 205 193 10 18
OMEPRAZOLE 203 203 11 6
MIRTAZAPINE 182 180 12 25
AMLODIPINE BESYLATE 180 178 13 5
POTASSIUM CHLORIDE 180 168 13 17
METOPROLOL TARTRATE 172 171 15 8
ATORVASTATIN CALCIUM 136 136 16 15
METOPROLOL SUCCINATE 121 121 17 12
KLOR-CON M20 121 120 17 34
QUETIAPINE FUMARATE 121 121 17 36
CLOPIDOGREL 117 117 20 30
ALENDRONATE SODIUM 101 95 21 21
HYDROCODONE-ACETAMINOPHEN 91 91 S3 22 7
PANTOPRAZOLE SODIUM 89 89 23 26
OXYBUTYNIN CHLORIDE ER 85 76 24 77
TAMSULOSIN HCL 85 85 24 28
LEVOFLOXACIN 79 77 26 80
CARVEDILOL 78 78 27 24
AMIODARONE HCL 74 74 28 122
AMOX TR-POTASSIUM CLAVULANATE 71 68 29 109
PLAVIX 70 70 30 47
KLOR-CON M10 68 68 31 89
FENTANYL 67 53 S2 32 41
TRAZODONE HCL 65 65 33 44
ATENOLOL 65 65 33 20
CARBIDOPA-LEVODOPA 61 61 35 45
NITROFURANTOIN MONO-MACRO 61 61 35 150
GLIPIZIDE 59 59 37 37
RISPERIDONE 52 40 38 39
POLYETHYLENE GLYCOL 3350 52 52 38 32
ZOLPIDEM TARTRATE 50 50 40 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.